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ABSTRACT 
We describe three unrelated patients of European descent carrying an overlapping 3q26.33-
3q27.2 microdeletion who share common clinical features: neonatal hypotonia, severe 
feeding problems, specific facial features, abnormal dentition, recurrent upper airways 
infections, developmental delay and severe growth impairment. One of the patients carries 
a smaller deletion and presents a milder phenotype. We propose that 3q26.33-3q27.2 
microdeletion may represent a novel condition caused by the haploinsufficiency of dosage 
sensitive genes, several of which are involved in brain development.  
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1. INTRODUCTION 
Intellectual disability (ID), isolated or associated with congenital anomalies, is a significant 
clinical and social problem, involving 1-3% of the general population worldwide [1]. 
Chromosomal microarray techniques can identify a submicroscopic unbalanced 
chromosomal rearrangement in up to 15% of patients affected by ID [2], occasionally 
leading to the identification of ‘new’ microdeletion/duplication syndromes. International 
databases of chromosome imbalance such as DECIPHER (http://decipher.sanger.ac.uk) 
are extremely useful in matching patients carrying similar chromosomal rearrangements. 
Here we describe three unrelated patients of European descent, 2 of them reported in 
DECIPHER data base, carrying an overlapping 3q26.33-3q27.2 microdeletion and sharing 
common clinical features. We therefore suggest that 3q26.33-3q27.2 microdeletion may 
represent a novel condition caused by the haploinsufficiency of dosage sensitive genes 
within this region. 
 
2. PATIENT DATA  
2.1 Patient 1  
Patient 1 was the only child of healthy non consanguineous parents who presented at 2 
years and 8 months of age. Intrauterine growth restriction (IUGR) was noted early in the 
pregnancy; biochemical screening for Down syndrome and serial ultrasound scan did not 
reveal placental or fetal abnormalities. The mother reported normal fetal movements. 
Cesarean section was performed at 32 weeks gestation due to growth arrest: birth weight 
was 1380 g (10-25th centile, according to Hall growth curves [3]), birth length 39.5 cm (10-
25th centile), head circumference (OFC) 29.5 cm (50th centile). In the neonatal period, he 
showed bronchopulmonary dysplasia of prematurity, marked hypotonia, muscular 
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hypotrophy, inguinal hernia and patent ductus arteriosus, which resolved after 
pharmacological treatment. Brain ultrasound, electroencephalography (EEG), routine blood 
analysis, plasma aminoacids and mucopolysaccharide screening were normal. 
The baby had severe feeding problems and gavage feeding was used for the first 2 months 
of life. Feeding difficulties have only slightly improved. At 6 years of age, he is not yet able 
to chew and can only eat homogenized food. Oral aversion and lack of appetite are 
consistently reported. Gastroesophageal reflux and frequent vomiting require continued 
omeprazole treatment. 
He also presented with recurrent upper airway infections, bladder diverticula, vesicoureteric 
reflux and retractile right testicle which required orchidopexy.  
Results of Auditory Brainstem Response (ABR) were inconclusive due to the patient's poor 
cooperation, however the parents did not suspect hearing difficulties. Ophthalmological 
examination revealed mild myopia and astigmatism (wears corrective lenses) and normal 
fundus oculi. 
He wears orthopedic insoles for pes planus. 
Development was delayed: head control was achieved at 10 months of age, he sat at 17 
months of age and babbled at 18 months of age. At 6 years of age, he has not developed 
speech and does not have bladder or bowel sphincter control. Teeth eruption was markedly 
delayed: at 6 years of age dentition is still incomplete, with the upper jaw more involved. 
Growth parameters at 2 years 8 months and 6 years of age all plotted between -3 and -4 
standard deviations (SD) (Table 1). Parental stature was at the 25th-50th centile (mother 
160cm and father 173 cm). 
On physical examination we noted thin skin with very little subcutaneous fat, mild pectus 
carinatum, mild kyphosis, joint laxity, clinodactyly of the fourth toes. The third toes overlap 
the fourth toes (also reported in the father). 
2.2 Patient 2 
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Patient 2 was the second child born to healthy unrelated parents. He was first seen in clinic 
at one month of age. He is now eighteen years of age. He was noted to have IUGR and was 
born by emergency Cesarean section at 37 weeks gestation. He needed resuscitation at 
birth for poor respiratory effort. His birth weight was 1590 g (<3rd centile [3]) and his OFC at 
birth was 29.5 cm (<3rd centile [3]). He was hypotonic with a prominent nasal bridge, short 
philtrum, micrognathia and undescended testes. At three hours of age he had a tonic 
seizure with apnoea. He had several more seizures over the first 24 hours of life. He was 
started on phenobarbital and broad spectrum antibiotics and the seizures resolved. An EEG 
showed no background seizure activity, cranial ultrasound was unremarkable apart from a 
small cyst adjacent to the choroid plexus, and blood chemistries and metabolic screening 
were normal. G-banded karyotype was reported as 46,XY.  
He was able to bottle feed initially, however, gastrostomy feeding was required from 2 to 13 
years of age for poor weight gain. He had conductive hearing loss and required grommets. 
He has micropenis and cryptorchidism and required testosterone therapy at puberty. He has 
pes planus and abnormal foot position for which he wears orthotics.  
His development was delayed. By 4 years of age he was walking and had several single 
words. He progressed to being able to speak in short sentences. He has a learning disability 
and behavioural difficulties.  
His teeth were slow to erupt and by the age of fifteen years he still had his primary dentition, 
despite his adult teeth erupting. He has bilateral keratoconus. At the age of 16.75 years, his 
height was 147.6 cm (-4SD) and his weight 30.8 kg (-3 to -4 SD). 
2.3 Patient 3 
Patient 2 was the second child of non-consanguineous healthy parents. Family history was 
non-contributory. She was evaluated at the genetics clinic at 11 years of age regarding a 
possible diagnosis of Williams-Beuren syndrome due to a history of failure to thrive, 
hypotonia, attention deficit disorder (ADHD) and an extremely friendly personality. The 
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pregnancy was complicated by chronic polyhydramnios and intrauterine growth restriction. 
A level 2 ultrasound had shown possible problem with the kidneys (ultrasound report 
unavailable). During the pregnancy, cigarette smoking was reported (5-10 cigarettes per 
day). Due to the risk of preterm labor, the mother was given cortisone at 32 weeks 
gestation. The child was born at 38 5/7 weeks gestational age via Cesarean section 
secondary to breech presentation; birth weight was 1975 g (<<3rd centile [3]), length 43.82 
cm (<<3rd centile [3]), OFC 32 cm (10-25th centile [3]). APGAR scores were 8/9. At birth the 
following features were noted: cutis aplasia of scalp (2,5 x 3,8 cm), with underlying bony 
defect, hypotonia, edema of the genitals, and sacral dimple. She had poor suck and swallow 
with feeding issues resulting in projectile vomiting, often through the nose. She cried 
inconsolably, stiffened frequently and had gastroesophageal reflux requiring therapy with 
ranitidine and metoclopramide. She required multiple formula changes and required two to 
three hours to take two to three ounces of formula. For many years, she had difficulty 
growing, prompting cystic fibrosis screening which was negative. Her weight did not 
normalize until approximately nine to ten years of age and she has become overweight for 
height since that time.  
Frequent episodes of abdominal pain, diarrhea and constipation were reported.  
Primary teeth loss was delayed and teeth were small, pointed, and crowded; all but one 
required extraction. Moreover, salivary thickening was noted. She choked frequently when 
drinking. 
The child has never had a seizure, but does stare for several minutes at a time. Brain MRI 
showed a 12 mm Chiari malformation, crowding of the foramen magnum, narrowing of the 
inferior fourth ventricle, limited flow of cerebrospinal fluid through the foramen magnum 
causing ventriculomegaly involving the third and lateral ventricles. Glasses were used 
because of astigmatism and myopia.  
Frequent episodes of otitis media were reported, with intermittent decreased hearing 
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secondary to fluid. She is very sensitive to loud noises, becoming anxious and upset. She 
was recently noted to have acanthosis nigricans and “pre-diabetes”. She reportedly urinates 
frequently and drinks excessively. She has enuresis and frequent daytime incontinence. 
She has a history of hypermobility of the hips. She has a history of eczema.  
Her development was delayed; she showed gross motor impairment with decreased hip 
strength and poor posture control with delays in fine motor skills. She walked at 20 month of 
age and language was slightly delayed. She had a learning disability and she required 
occupational, physical, speech therapy, and social skills training. 
She excels in verbal areas, spelling, and reading, has average working memory, and has 
difficulty with maths and step-wise work.  She learned to tie her shoes at age 11 years of 
age.  She has inconsistent visual skills and poor writing skills. She was diagnosed with 
ADHD, is overly affectionate with those around her and has an extreme sense of empathy.  
At 12 years 1 month of age, her height was at the 3rd centile, OCF at 10th centile, and weight 
at 50th centile. Paternal stature was 178 cm (50-75th centile [3]) and maternal stature was 
178 cm (>95th centile [3]).  
On physical examination we noted frontal bossing and mild temporal narrowing. Ears were 
mildly simple and somewhat thickened, measuring 5.2 cm (-2SD). Eyes had mildly narrow 
horizontal openings with normal slant. She had fused lower incisors, mildly flat and short 
philtrum, and mild retrognathia. Her labia minora were hypoplastic with a hypoplastic pubic 
pad. Fingers were mildly tapered with mild flattening of the ulnar border. She had multiple 
freckles of the left forearm and café au lait spot of left lower flank with mildly decreased 
tone. 
 
3. METHODS AND RESULTS  
3.1 Patient 1 
Array-CGH performed using Human Genome CGH Microarray Kit 4 x 44K (Agilent) 
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detected a de novo 4.14 Mb microdeletion from 181.648.378 (3q26.33) to 185.786.898  
(3q27.2). This result was confirmed through FISH (BAC – Sanger Center- RP11-63M3 
3q27.1); the same FISH has been performed to analyze parents’ samples. The deletion 
involves 43 genes (Genome assembly Feb. 2009 – UCSC hg19) (Fig. 1).  
3.2 Patient 2 
Array-CGH performed using a Sanger 1Mb BAC array (Build 36) detected a de novo 4.28 
Mb microdeletion from 181.692.255 (3q26.33) to 185.969.168 (3q27.2). This result was 
confirmed by re analysis of the G-banded Karyotype which demonstrated that in hindsight 
the deletion was visible microscopically.  The deletion involves 44 genes (Genome 
assembly Feb. 2009 – UCSC hg19) (Fig. 1). Parental samples were analyzed by. G-banded 
karyotype and these showed no evidence of the microdeletion. This confirmed that the 
deletion had arisen as a de novo event. 
3.3 Patient 3 
Array-CGH performed using Affymetrix 6.0SNP array kit detected a 2.09 Mb microdeletion 
from 183.047.473 (3q27.1) to 185.140.522 (3q27.2). This result was confirmed through 
FISH. The deletion involves 36 genes (Genome assembly Feb. 2009 – UCSC hg19) (Fig. 
1). Maternal testing via FISH was normal (BAC-RP11-63G1 3q27.1-q27). Father unable to 
be tested to date. 
 
4. DISCUSSION 
Three patients are described with an overlapping 3q26.33-3q27.2 microdeletion, sharing 
specific features that could make this phenotype clinically recognizable (Fig. 2; Table 1). 
Patient 3 carries a smaller deletion, entirely embedded within the region deleted in the other 
two patients, and presents a milder phenotype, mainly with respect to intellectual disability 
and growth.  
This disorder is possibly secondary to contiguous gene deletion. At least 40 genes are 
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located within this region (Fig. 1). At least six genes may be involved in brain development 
and function, particularly: DCUN1D1, for which the mouse ortholog is expressed in 
proliferating neuroblasts [4]; DVL3, a  regulator of cell proliferation and neuroblast 
specification [5]; several genes belonging to the serotonin receptor family (HTR3C, HTR3D, 
HTR3E); KLHL24, involved in functional regulation of glutamate receptors [6]; MAP6D1, a 
neuronal protein that binds microtubules and plays a role in synaptic function in neuritis [7]. 
Several of the genes included in the deletion have already been associated with human 
pathologies, with both autosomal recessive and dominant transmission. Our patients did not 
show any symptoms of autosomal recessive diseases associated with mutations in the 
genes mapping to this region (e.g. ALG3, MCCC1, EIF2B5, LIPH) and therefore we did not 
sequence the contralateral alleles. 
Within the common deleted region is the gene THPO.  Gain of function mutations in this 
gene have been shown to be responsible for hereditary thrombocythaemia [8,9].  
Patient 1 showed reduced platelet concentration (127x103/ul, n.v. 150-400) and patient 3 
had platelet concentration at the low end of normal (168x103/ul, n.v. 140-400). Further 
assessment of the possible role of deletion of THPO in thrombocytopenia may be 
appropriate.  
CLCN2, a gene for which the mice knock-out model of its homolog demonstrates 
leukoencephalopathy [10] and degeneration of retinal and testicular cells, leading to male 
infertility is present in the deleted region [11].  The CLCN2 rat homolog is expressed in fetal 
lung and its expression rapidly decreases after birth; therefore its deficiency may be related 
to the neonatal respiratory distress [12] and testicular anomalies observed in our patients. 
Several genes related to body growth are present in the deleted region. In all three patients  
PARL is deleted: the knock-out mouse (Parl -/-) shows growth retardation, cachexia and 
muscle atrophy. In patients 1 and 2 the ETV5 gene is deleted.  These patients present with 
more severe growth impairment than patient 3. ETV5 is a member of the ETS transcription 
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factors, ubiquitously expressed during development and adulthood. ETV5 homolog knock-
out mice show a progressive loss of spermatogonial stem cells and reduced body weight 
[13].  
Several segmental duplications have been reported close to the deleted regions’ 
breakpoints. The three deletions present in our patients did not share common breakpoints, 
and cannot be considered recurrent CNVs, but it could be postulated that the whole region 
might be susceptible to non-homologous recombinations leading to chromosomal 
rearrangements. 
In conclusion, based on our observations, we propose that 3q26.33-3q27.2 microdeletion 
constitutes a new clinically recognizable syndrome characterized by growth deficiency, 
severe feeding problems, hypotonia, muscular hypotrophy, dysmorphic features, and 
intellectual disability. 
Clinical and molecular characterization of additional patients with a similar chromosomal 
deletion are needed to further delineate the phenotype and refine the minimal critical region. 
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LEGENDS OF FIGURES  
Figure 1: schematic representation of 3q26.33-3q27.1 region with the minimal overlapping 
microdeletion and genes involved. Segmental duplications are indicated in pale grey when 
the level of similarity is 93 - 95.99%, and dark grey when 90 - 92.99%. 
 
Figure 2: Patient 1 (A and B: age 6 years), Patient 2 (C and D: age 8, E and F: age 11), 
Patient 3 (G and H: age 1 years). Note common dysmorphisms: flat facial profile, medially 
sparse eyebrows, epicanthal folds, flat nasal bridge and tip, mild shortening of the philtrum  
Patient 1 and 2 share also downturned corners of mouth and small and spaced teeth at the 
lower jaw. In Patient 1, note also anteverted nares. 
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TABLE 
 
Table 1: comparison of patients’ clinical features 
 
Phenotypic 
characteristic 
Patient 1 Patient 2 Patient 3 
DECIPHER ID 257773 1495 - 
Sex Male Male Female 
Age at last 
examination 
6 years 17 years 12 years 
Size of the deletion 4.14 Mb 4.28 Mb 2.09 Mb 
IUGR Yes Yes Yes 
Birth parameters 
Gestational age 
Birth weight 
Birth length 
OCF at birth 
 
32 w.g. 
1380 g (-1.22 SD) 
39,5 cm (-1.21 SD) 
29,5 cm (-0.28 SD) 
 
37 w.g. 
1590 g (-3.03 SD) 
 
29,5 cm(-3.16 SD) 
 
38+5 w.g. 
1975 g (-3.53 SD) 
43,82 cm (-4.12 SD) 
32 cm (-3.20 SD) 
Feeding problems Yes Yes Yes 
Slender habitus/little 
subcutaneous fat 
 
Yes Yes Until age 10 years 
Height (at last 
examination) 
98 cm (-3.68 SD) 147.6 cm (-4 SD) 136.2 cm (-2 SD) 
Weight (at last 
examination) 
13 Kg (-3.62 SD) 30.8 kg (-3/-4 SD) 40.8 kg (0 SD) 
OCF (at last 46 cm (-4.44 SD)  51.2 cm (-1.15 SD) 
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examination) 
dysmorphic features 
flat facial profile 
medially sparse 
eyebrows 
epicanthal folds 
flat nasal bridge and 
tip 
anteverted nares 
short philtrum 
downturned corners 
of mouth 
 
Yes 
Yes 
 
Yes 
Yes 
 
Yes 
Yes 
Yes 
 
 
Yes 
Yes 
 
Yes 
Yes 
 
No 
Yes 
Yes 
 
Yes 
Yes 
 
Yes 
Yes 
 
No 
Mild 
No 
Eyes Myopia/astigmatism 
Bilateral 
keratoconus 
Myopia/astigmatism 
Teeth  
at 6 years dentition 
is incomplete (upper 
jaw more 
compromised) 
at 15 years still had 
primary dentition, 
despite adult teeth 
erupting 
pointed, delayed 
falling out, wide 
spaced, fused lower 
incisors 
Ears Preauricular pit  
mildly simple and  
thickened 
Thin skin Yes Yes No 
Hand Clinodactyly IV digit  
Mildly tapered 
fingers/flattening of 
the ulnar border 
Foot Pes planus Pes planus Mild pes planus 
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Skeletal 
Mild kyphosis 
Mild pectus 
carenatum 
 
hypermobility of the 
hips 
Genitalia 
Retractable lift 
testicle 
Undescended testes 
Micropenis 
Hypoplastic labia 
minora and pubic 
pad 
Psychomotor development  
Delayed milestones Yes Yes Yes 
Speech Not acquired Speaks in sentences Good 
Walking Not acquired 4 years 20 months 
Mental retardation Severe Severe 
Learning disability, 
borderline IQ 
Behaviour Normal Hyperactivity ADHD 
Neurology Hypotonia 
Hypotonia 
Tonic seizure at 
birth 
Hypotonia 
Chiari malformation, 
Ventricular 
malformations 
    
Other abnormalities Recurrent upper 
airway infections 
Patent ductus 
arteriosus 
Gastroesophageal 
reflux 
Inguinal hernia 
Bladder diverticula 
Recurrent otitis 
media 
Mild hearing 
impairment 
(grommets) 
Delayed puberty 
(testosterone 
therapy at puberty) 
Recurrent otitis 
media 
Gastroesophageal 
reflux 
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